RMC
ALXN

Resources Management Corp’s Alexion Pharmaceuticals ALXN Stock Holding History

Resources Management Corp’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,615
Closed -$1.03M – 514
2021
Q2 		$1.03M Sell
5,615
-4,770
-46% -$819K 0.15% 127
2021
Q1 		$1.59M Sell
10,385
-170
-2% -$26.3K 0.24% 85
2020
Q4 		$1.65M Buy
10,555
+285
+3% +$36.6K 0.27% 80
2020
Q3 		$1.18M Buy
10,270
+1,205
+13% +$130K 0.21% 92
2020
Q2 		$1.02M Buy
9,065
+3,320
+58% +$352K 0.19% 92
2020
Q1 		$516K Buy
5,745
+3,466
+152% +$340K 0.12% 120
2019
Q4 		$246K Sell
2,279
-210
-8% -$22.5K 0.04% 198
2019
Q3 		$244K Buy
+2,489
New +$281K 0.05% 199
2018
Q4 		$268K Sell
2,759
-900
-25% -$106K 0.06% 185
2018
Q3 		$508K Buy
+3,659
New +$459K 0.09% 160

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Resources Management Corp's ALXN Position: Q3 2021 in Review

Resources Management Corp sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 5,615 shares — an estimated $1.03M sold.

Resources Management Corp first reported a position in ALXN in Q3 2018 and held it in 10 quarters. The position peaked at $1.65M in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Resources Management Corp reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Resources Management Corp sold 5,615 Alexion Pharmaceuticals shares in Q3 2021, an estimated $1.03M.
  • Resources Management Corp first reported a position in Alexion Pharmaceuticals in Q3 2018 and held it in 10 quarters.
  • Resources Management Corp's Alexion Pharmaceuticals position peaked at $1.65M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Resources Management Corp's 13F filing for Q3 2021, filed 12 Nov 2021.